Global Oncofertility Market Overview:
Global Oncofertility Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Oncofertility Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Oncofertility involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Oncofertility Market:
The Oncofertility Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Oncofertility Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Oncofertility Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Oncofertility market has been segmented into:
Oocyte Cryopreservation
Sperm Banking
Embryo Cryopreservation
Testicular Tissue Cryopreservation
By Application, Oncofertility market has been segmented into:
Cancer
Autoimmune Diseases
Genetic Disorders
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Oncofertility market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Oncofertility market.
Top Key Players Covered in Oncofertility market are:
EMD Serono
Merck
Irvine Scientific
Vitrolife
Reproductive Health Specialists
Reproductive Medicine Associates of New Jersey
AbbVie
OvaScience
Cook Medical
Genea
Bayer
Ferring Pharmaceuticals
SAGE Publishing
Care Fertility
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Oncofertility Market Type
4.1 Oncofertility Market Snapshot and Growth Engine
4.2 Oncofertility Market Overview
4.3 Oocyte Cryopreservation
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Oocyte Cryopreservation: Geographic Segmentation Analysis
4.4 Sperm Banking
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Sperm Banking: Geographic Segmentation Analysis
4.5 Embryo Cryopreservation
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Embryo Cryopreservation: Geographic Segmentation Analysis
4.6 Testicular Tissue Cryopreservation
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Testicular Tissue Cryopreservation: Geographic Segmentation Analysis
Chapter 5: Oncofertility Market Application
5.1 Oncofertility Market Snapshot and Growth Engine
5.2 Oncofertility Market Overview
5.3 Cancer
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Cancer: Geographic Segmentation Analysis
5.4 Autoimmune Diseases
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Autoimmune Diseases: Geographic Segmentation Analysis
5.5 Genetic Disorders
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Genetic Disorders: Geographic Segmentation Analysis
5.6 Others
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.6.3 Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Oncofertility Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 EMD SERONO
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 MERCK
6.4 IRVINE SCIENTIFIC
6.5 VITROLIFE
6.6 REPRODUCTIVE HEALTH SPECIALISTS
6.7 REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY
6.8 ABBVIE
6.9 OVASCIENCE
6.10 COOK MEDICAL
6.11 GENEA
6.12 BAYER
6.13 FERRING PHARMACEUTICALS
6.14 SAGE PUBLISHING
6.15 CARE FERTILITY
Chapter 7: Global Oncofertility Market By Region
7.1 Overview
7.2. North America Oncofertility Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Oocyte Cryopreservation
7.2.2.2 Sperm Banking
7.2.2.3 Embryo Cryopreservation
7.2.2.4 Testicular Tissue Cryopreservation
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Cancer
7.2.3.2 Autoimmune Diseases
7.2.3.3 Genetic Disorders
7.2.3.4 Others
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Oncofertility Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Oocyte Cryopreservation
7.3.2.2 Sperm Banking
7.3.2.3 Embryo Cryopreservation
7.3.2.4 Testicular Tissue Cryopreservation
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Cancer
7.3.3.2 Autoimmune Diseases
7.3.3.3 Genetic Disorders
7.3.3.4 Others
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Oncofertility Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Oocyte Cryopreservation
7.4.2.2 Sperm Banking
7.4.2.3 Embryo Cryopreservation
7.4.2.4 Testicular Tissue Cryopreservation
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Cancer
7.4.3.2 Autoimmune Diseases
7.4.3.3 Genetic Disorders
7.4.3.4 Others
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Oncofertility Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Oocyte Cryopreservation
7.5.2.2 Sperm Banking
7.5.2.3 Embryo Cryopreservation
7.5.2.4 Testicular Tissue Cryopreservation
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Cancer
7.5.3.2 Autoimmune Diseases
7.5.3.3 Genetic Disorders
7.5.3.4 Others
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Oncofertility Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Oocyte Cryopreservation
7.6.2.2 Sperm Banking
7.6.2.3 Embryo Cryopreservation
7.6.2.4 Testicular Tissue Cryopreservation
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Cancer
7.6.3.2 Autoimmune Diseases
7.6.3.3 Genetic Disorders
7.6.3.4 Others
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Oncofertility Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Oocyte Cryopreservation
7.7.2.2 Sperm Banking
7.7.2.3 Embryo Cryopreservation
7.7.2.4 Testicular Tissue Cryopreservation
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Cancer
7.7.3.2 Autoimmune Diseases
7.7.3.3 Genetic Disorders
7.7.3.4 Others
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Oncofertility Scope:
|
Report Data
|
Oncofertility Market
|
|
Oncofertility Market Size in 2025
|
USD XX million
|
|
Oncofertility CAGR 2025 - 2032
|
XX%
|
|
Oncofertility Base Year
|
2024
|
|
Oncofertility Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
EMD Serono, Merck, Irvine Scientific, Vitrolife, Reproductive Health Specialists, Reproductive Medicine Associates of New Jersey, AbbVie, OvaScience, Cook Medical, Genea, Bayer, Ferring Pharmaceuticals, SAGE Publishing, Care Fertility.
|
|
Key Segments
|
By Type
Oocyte Cryopreservation
Sperm Banking
Embryo Cryopreservation
Testicular Tissue Cryopreservation
By Applications
Cancer
Autoimmune Diseases
Genetic Disorders
Others
|
